<DOC>
	<DOCNO>NCT00645515</DOCNO>
	<brief_summary>The purpose study compare safety ziprasidone risperidone treatment chronic schizophrenia . The primary purpose differentiate effect ziprasidone risperidone extrapyramidal side effect secondary purpose compare tolerability efficacy .</brief_summary>
	<brief_title>A Study Comparing Safety Efficacy Ziprasidone Risperidone Treatment Chronic Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnosis schizophrenia CGIS score 4 less baseline Concurrent antipsychotic treatment Treatment antidepressant mood stabilizer within 2 week randomization Acute exacerbation schizophrenia within 3 month baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>